Dorsata is a trailblazing health tech startup that envisions a superior electronic health record (EHR) experience for women's health care providers, life sciences, and health plans. Established in 2012 and headquartered in Arlington, VA, the company focuses on leveraging real-world data to drive advancements in the Health Care and Information Technology sectors.
With the recent $5.20M Series A investment in April 2020, Dorsata has attracted a consortium of prominent investors, including QED Investors, 1776 Ventures, Motley Fool Ventures, Gore Range Capital, LabCorp, and Women's Health USA. This significant funding is a testament to the company's potential and market relevance.
The startup's flagship product, developed in collaboration with hundreds of Ob-Gyns, enables seamless integration into obstetrics workflows, thereby enhancing patient care and aggregating rich, structured clinical data. By establishing a nationwide network of providers and patients, Dorsata's EHR tool is poised to disrupt the traditional paradigms of women's health care technology.
Through this innovative approach, Dorsata not only aims to elevate the EHR experience for Ob-Gyns but also aspires to provide invaluable real-world data for the Life Sciences sector. This holistic vision and tangible execution underscore Dorsata's potential to carve a significant niche in the evolving landscape of health technology and data-driven patient care.